OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

NCT06781944 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: Obinutuzumab
DRUG: CTX combined with Glucocorticoids

Sponsor

Huashan Hospital